These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 15264875

  • 21. Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
    Zhang K, An R, Gao Z, Zhang Y, Aruva MR.
    Nucl Med Biol; 2006 May; 33(4):505-12. PubMed ID: 16720242
    [Abstract] [Full Text] [Related]

  • 22. In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonyl.
    D'Andrea LD, Testa I, Panico M, Di Stasi R, Caracò C, Tarallo L, Arra C, Barbieri A, Romanelli A, Aloj L.
    Biopolymers; 2008 May; 90(5):707-12. PubMed ID: 18615495
    [Abstract] [Full Text] [Related]

  • 23. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 24. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J, Mikołajczak R, Czepczyński R, Ziemnicka K, Gryczyńska M, Sowiński J.
    Cancer Biother Radiopharm; 2007 Oct 22; 22(5):613-28. PubMed ID: 17979564
    [Abstract] [Full Text] [Related]

  • 25. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Yurt Lambrecht F, Durkan K, Ozgür A, Gündüz C, Avcı CB, Susluer SY.
    J Drug Target; 2013 May 22; 21(4):383-8. PubMed ID: 23301856
    [Abstract] [Full Text] [Related]

  • 26. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M, Berger S, Poethko T, Schwaiger M, Wester HJ.
    Bioconjug Chem; 2008 Jun 22; 19(6):1256-68. PubMed ID: 18510351
    [Abstract] [Full Text] [Related]

  • 27. Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
    Harris TD, Kalogeropoulos S, Nguyen T, Dwyer G, Edwards DS, Liu S, Bartis J, Ellars C, Onthank D, Yalamanchili P, Heminway S, Robinson S, Lazewatsky J, Barrett J.
    Bioconjug Chem; 2006 Jun 22; 17(5):1294-313. PubMed ID: 16984141
    [Abstract] [Full Text] [Related]

  • 28. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 22; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 29. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L, Panico MR, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M.
    Biopolymers; 2002 Feb 22; 66(6):370-80. PubMed ID: 12658724
    [Abstract] [Full Text] [Related]

  • 30. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C, Zhao H, Yang S, Shi J, Huang J, Cui L, Zhong L, Jin X, Li F, Liu Z, Jia B, Wang F.
    Mol Pharm; 2013 Aug 05; 10(8):2925-33. PubMed ID: 23768172
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and in vitro/in vivo evaluation of novel 99mTc(CO)3-folates.
    Müller C, Schubiger PA, Schibli R.
    Bioconjug Chem; 2006 Aug 05; 17(3):797-806. PubMed ID: 16704220
    [Abstract] [Full Text] [Related]

  • 32. (99m)Tc-labeled SWL specific peptide for targeting EphA2 receptor.
    Liu Y, Lan X, Wu T, Lang J, Jin X, Sun X, Wen Q, An R.
    Nucl Med Biol; 2014 Jul 05; 41(6):450-6. PubMed ID: 24768147
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D, Béhé M, Walter MA, Chen J, Powell P, Mikolajczak R, Mäcke HR.
    J Nucl Med; 2005 Sep 05; 46(9):1561-9. PubMed ID: 16157541
    [Abstract] [Full Text] [Related]

  • 34. Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
    Surfraz MB, King R, Mather SJ, Biagini SC, Blower PJ.
    J Med Chem; 2007 Mar 22; 50(6):1418-22. PubMed ID: 17315986
    [Abstract] [Full Text] [Related]

  • 35. Development of a (99m)Tc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors.
    Shamshirian D, Erfani M, Beiki D, Fallahi B, Shafiei M.
    Ann Nucl Med; 2015 Oct 22; 29(8):709-20. PubMed ID: 26152564
    [Abstract] [Full Text] [Related]

  • 36. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A, Khazaeli MB, Safavy K, Mayo MS, Buchsbaum DJ.
    Clin Cancer Res; 1999 Oct 22; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [Abstract] [Full Text] [Related]

  • 37. Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.
    Trejtnar F, Laznicek M, Laznickova A, Kopecky M, Petrik M, Béhé M, Schmidt J, Maecke H, Maina T, Nock B.
    Anticancer Res; 2007 Oct 22; 27(2):907-12. PubMed ID: 17465219
    [Abstract] [Full Text] [Related]

  • 38. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
    Müller C, Schubiger PA, Schibli R.
    Nucl Med Biol; 2007 Aug 22; 34(6):595-601. PubMed ID: 17707798
    [Abstract] [Full Text] [Related]

  • 39. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH.
    Mol Pharm; 2011 Aug 01; 8(4):1165-73. PubMed ID: 21699202
    [Abstract] [Full Text] [Related]

  • 40. The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies.
    Agostini S, Bolzati C, Didonè E, Cavazza-Ceccato M, Refosco F, Aloj L, Arra C, Aurilio M, Tornesello AL, Tesauro D, Morelli G.
    J Pept Sci; 2007 Apr 01; 13(4):211-9. PubMed ID: 17269133
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.